ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

RedHill Biopharma Limited · 2016
ClinicalTrials.gov · Datasets · License: Public Domain · 2016
Open Source ↗
irritable bowel syndrome with diarrhea, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 832394
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.